Embracing the noise and bias in healthcare data

Real-world patient data was not collected with the goal to personalize patient care, yet many attempts to repurpose this data for finding optimal treatments focus on fitting messy, noisy, and biased real-world data into pristine data models. This not only requires expensive and time-consuming cleaning processes but also strips away potentially valuable signals. However, by […]


Droice Labs featured in Health Innovators Show

Droice Labs featured in the Health Innovators Show is a podcast hosted by Dr. Roxie Mooney, a seasoned healthcare commercialization strategist and marketing professional with over a decade of experience helping healthcare startups commercialize and scale up their business. Mayur Saxena from Droice Labs shares his insights from building a health technology company.


Droice Labs part of 2021 Pharmstars accelerator cohort

Pharmstars accelerator selects startups into digital health solutions, digital biomarkers, patient engagement, clinical trial recruitment, novel drug delivery mechanisms, real-world evidence (RWE) collection, and data analysis to partner with top pharma companies including Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Sumitovant Biopharma, and others.


Pharma-focused digital health accelerator PharmStars completes its inaugural program

PharmStars, a digital health accelerator focused on forging relationships between digital health companies and the life science world, has announced the culmination of its first 10-week program focused on clinical trial innovation. The cohort included 12 digital health startups and involved six life science members, including Alexion AstraZeneca Rare Disease, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Sumitovant Biopharma and Takeda.